Merck KGaA Names Garijo to Run Serono Biotechnology Unit - Bloomberg

26-09-2013 BloombergComments (0)

Pharmaceutical

Merck KGaA (MRK) promoted a former Sanofi executive to run its pharmaceutical business as it seeks to overcome competition and drug development setbacks that have dragged down sales. Belen Garijo, 53, will become president and chief executive officer ...

Read more on Bloomberg

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top